A Study to Evaluate Whether MRI Sequence Using Scans of Humans Can Improve Current Techniques

Overview

About this study

The purpose of this study is to evaluate whether newly developed acquisition techniques or 1.5 Tesla and 3.0 Tesla MRI scanners systems can provide improvements over current acquisition techniques. The objective of this protocol is to allow investigators to perform initial test evaluation in humans of new MRI acquisition techniques.  

All pulse sequences, including the ones that we testing, can be used on FDA-approved MRI scanners as long as they meet FDA guidelines for non-significant risk, and our new sequences all meet these guidelines.

All MRI test scans of new pulse sequences will be performed subject to FDA guidelines which have been determined to pose Non-Significant Risk.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Male and female adults, ≥ 18 years of age.

Exclusion Criteria:

  • Individuals < 18 years of age.
  • Participants who are unable to undergo MR (claustrophobia, implanted device, etc.), pregnancy, obesity (> 400 lbs.).

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Stephen Riederer, Ph.D.

Open for enrollment

Contact information:

Kathy Brown

(507) 538-1321

brown.kathy@mayo.edu

More information

Publications

Publications are currently not available